A model for bone remodeling that includes PTH is proposed.
PTHrP is included to account for the vicious cycle of bone metastases.
PK/PD of bisphosphonates, denosumab and chemotherapy are included as treatment.
Model simulations illustrate how anti-cancer and anti-resorptive therapies on bone metastases can reduce tumor burden and restore bone health.